Eagan, Minnesota-based immune health company Biothera Inc. announced Wednesday that it has begun dosing patients for its phase 3 clinical trial to evaluate a new drug to treat late-stage colorectal cancer. Biothera has developed the Imprime PGG drug that it is testing in combination with another drug — cetuximab (Erbitux), which is approved to treat […]
Biothera has raised $3.5 million and the company doesn’t want to stop there, as it aims to push that total to $25 million, according to a Securities and Exchange Commission filing. The 53-employee biotech firm markets itself as “the immune health company” and is split into two business units. The first is developing a drug […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.